Registered report: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

eLife

Volumn 4, Issue JULY 2015, 2015, Pages

  Li, Jia ^a   Lam, Matthew ^b   Iorns, Elizabeth ^c   Gunn, William ^d   Tan, Fraser ^c   Lomax, Joelle ^c   Errington, Timothy ^e  

^a Crown Bioscience Inc   (United States)

^b Breakthrough Breast Cancer   (United Kingdom)

^c Science Exchange   (United States)

^d ELSEVIER MASSON   (France)

^e CENTER FOR OPEN SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V ANTIGEN; MICRORNA 34A; CD44 PROTEIN, HUMAN; HERMES ANTIGEN; MICRORNA; MIRN34 MICRORNA, HUMAN;

ARTICLE; CLINICAL PROTOCOL; HUMAN; LUCIFERASE ASSAY; META ANALYSIS (TOPIC); METASTASIS; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING; BIOSYNTHESIS; DOWN REGULATION; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; STEM CELL;

ANTIGENS, CD44; DOWN-REGULATION; HUMANS; MALE; MICRORNAS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; STEM CELLS;

EID: 84938394354     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.06434     Document Type: Article

References (21)

1. Abel EL, Angel JM, Kiguchi K, DiGiovanni J. 2009. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nature Protocols 4:1350–1362. doi: 10.1038/nprot.2009.120.
2. Achari C, Winslow S, Ceder Y, Larsson C. 2014. Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells. BMC Cancer 14:538. doi: 10.1186/1471-2407-14-538.
3. Basak SK, Veena MS, Oh S, Lai C, Vangala S, Elashoff D, Fishbein MC, Sharma S, Rao NP, Rao D, Phan R, Srivatsan ES, Batra RK. 2013. The CD44high tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression. PLOS ONE 8:e73195. doi: 10.1371/journal.pone.0073195.
4. Corney DC, Hwang C-I, Matoso A, Vogt M, Flesken-Nikitin A, Godwin AK, Kamat AA, Sood AK, Ellenson LH, Hermeking H, Nikitin AY. 2010. Frequent downregulation of miR-34 family in human ovarian cancers. Clinical Cancer Research 16:1119–1128. doi: 10.1158/1078-0432.CCR-09-2642.
5. Errington TM, Iorns E, Gunn W, Tan FE, Lomax J, Nosek BA. 2014. An open investigation of the reproducibility of cancer biology research. eLife 3:e04333. doi: 10.7554/eLife.04333.
6. Fan Q. 2013. miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44. Oncology Reports 29:1027–1036. doi: 10.3892/or.2013.2234.
7. Faul F, Erdfelder E, Lang AG, Buchner A. 2007. G* Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 39:175–191. doi: 10.3758/BF03193146.
8. Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ, Tang DG. 2009. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27:993–1005. doi: 10.1002/stem.29.
9. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D, Xu L. 2008. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 8:266. doi: 10.1186/1471-2407-8-266.
10. Jin K, Xiang Y, Tang J, Wu G, Li J, Xiao H, Li C, Chen Y, Zhao J. 2013. miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells. Tumor Biology 35: 1503–1510. doi: 10.1007/s13277-013-1207-z.
11. Li H, Jiang M, Honorio S, Patrawala L, Jeter CR, Calhoun-Davis T, Hayward SW, Tang DG. 2009. Methodologies in assaying prostate cancer stem cells. Methods in Molecular Biology 568:85–138. doi: 10.1007/978-1-59745-280-9_7.
12. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG. 2011. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Medicine 17:211–215. doi: 10.1038/nm.2284.
13. Maroof H, Salajegheh A, Smith RA, Lam AK. 2014. Role of microRNA-34 family in cancer with particular referenceto cancer angiogenesis. Experimental and Molecular Pathology 97:298–304. doi: 10.1016/j.yexmp.2014.08.002.
14. Misso G, Di Martino MT, De Rosa G, Farooqi AA, Lombardi A, Campani V, Zarone MR, Gullà A, Tagliaferri P, Tassone P, Caraglia M. 2014. Mir-34: a new weapon against cancer? Molecular Therapy. Nucleic Acids 3:e194. doi: 10.1038/mtna.2014.47.
15. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG. 2006. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25:1696–1708. doi: 10.1038/sj.onc.1209327.
16. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. 2005. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Research 65:6207–6219. doi: 10.1158/0008-5472.CAN-05-0592.
17. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. 2007. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+ 2 1+ cell population is enriched in tumor-initiating cells. Cancer Research 67:6796–6805. doi: 10.1158/0008-5472.CAN-07-0490.
18. Siemens H, Jackstadt R, Hünten S, Kaller M, Menssen A, Götz U, Hermeking H. 2014. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 10:4256–4271. doi: 10.4161/cc.10.24.18552.
19. Siemens H, Jackstadt R, Kaller M, Hermeking H. 2013. Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget 4:1399–1415.
20. Toyooka S. 2013. Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells. Oncology Reports 29:2169–2174. doi: 10.3892/or.2013.2351.
21. Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D, Bader AG. 2010. Development of a lung cancer therapeutic based on the tumor suppressor MicroRNA-34. Cancer Research 70:5923–5930. doi: 10.1158/0008-5472.CAN-10-0655.